Figure 3From: The challenge to avoid anti-malarial medicine stock-outs in an era of funding partners: the case of Tanzania Malaria prevalence (top panel) and average annual total stock-out rate of artemisinin combination therapy in health facilities (bottom panel) by region in 2011–2012 in mainland Tanzania. Back to article page